U.S. Energy Services Stock News

National Storage Affiliates Trust recently reported third-quarter results, reaffirmed its full-year 2025 earnings guidance, and announced a new US$350 million joint venture with Investment Real Estate Management to target value-add self storage investments. This collaboration gives NSA increased acquisition capacity and introduces a preferred equity return structure, reflecting its ongoing focus on portfolio expansion despite challenging operating conditions. We'll explore how the new joint...

Trump Media and Technology Group Corp. recently announced that it is expanding its Truth Social platform by integrating prediction markets through an exclusive partnership with Crypto.com, launching the new “Truth Predict” product for major event forecasting. This move positions Trump Media as an early adopter in combining social media and prediction markets, offering users engagement beyond traditional social networking. We'll explore how introducing real-money prediction contracts could...

Macerich (MAC) remains unprofitable as net losses have expanded at an average rate of 10.4% per year over the past five years, and margin performance is yet to show improvement. Revenue growth is projected at just 1.8% per year, lagging well behind the broader US market’s pace of 10.5%. Despite these challenges, earnings are forecast to surge 89.5% per year with a return to profitability expected within the next three years. This outlook has drawn investor attention, especially with the share...

Dine Brands Global (DIN) posted a net profit margin of 5.3%, down from 10.9% a year ago. Although the company has averaged an impressive 28.9% annual earnings growth over the past five years, the most recent year bucked that trend with negative growth, and revenue is forecast to inch up at just 1.5% per year, which is well behind the US market’s 10.5% pace. For investors, the story right now is one of shrinking margins and muted near-term growth. However, value-focused buyers may see...

Chemed (CHE) shares drew focus after the company posted lower earnings for the third quarter. The company cited higher costs in its hospice business and slimmer margins in Roto-Rooter, despite reporting revenue growth. See our latest analysis for Chemed. Chemed’s latest update comes after a challenging period for shareholders. While earnings guidance was reaffirmed and a share buyback completed, third-quarter results missed the mark and a major fund trimmed its holdings. Together these...

Earlier this month, NEO Home Loans announced the appointment of Bri Lees as Head of Marketing to drive brand strategy and deepen integration between its advisor network and Better Home & Finance's digital mortgage platform. This leadership move underscores the company's commitment to scaling its technology-driven approach at a time when industry voices are drawing attention to its transformational ambitions. We’ll explore how the endorsement from activist investor Eric Jackson highlights...

Vulcan Materials Company recently reported strong third-quarter financial results, highlighting year-over-year increases in sales, net income, and earnings per share, and reaffirmed its focus on growth through aggregates-led acquisitions as well as efficiency initiatives. An interesting development is the company's continued commitment to identifying mergers and acquisitions targets, despite a quieter market, with leadership citing positive market conditions and an active pipeline of...

Abercrombie & Fitch recently launched major sales promotions, including a 25% off Black Friday event and a secret Fall Favorites sale, featuring discounted popular collections and early sign-up incentives for shoppers. Despite these efforts to drive traffic and refresh product appeal, analysts have issued negative earnings revisions for the upcoming quarter, pointing to ongoing profitability concerns even as revenue is projected to rise. We'll explore how analyst downgrades and profit margin...

CytomX Therapeutics (CTMX) has drawn fresh attention after announcing plans to share initial translational and biomarker data for CX-801 at the Society for Immunotherapy of Cancer Annual Meeting. This reveal highlights immune activation in advanced melanoma and furthers the company's oncology ambitions. See our latest analysis for CytomX Therapeutics. Recent excitement around CytomX Therapeutics isn’t just about their upcoming clinical data. The stock’s momentum is hard to miss. Shares have...

Thinking about whether LyondellBasell Industries is worth a spot in your portfolio? You're not alone; many investors are eyeing the stock, curious if there's value hiding beneath the headlines. The share price has dropped by 44.8% over the past year, with a further 5.9% slip in the last week. This highlights just how quickly market sentiment and risk perception can change. Recent news about ongoing strategic reviews and the company's announced cost-cutting initiatives have added fuel to the...

Fiserv (NYSE:FI) is under the spotlight after its stock tumbled 47% following a sharp miss in third quarter results, slashed guidance, and a high-profile securities fraud class action lawsuit. The leadership shake-up and legal heat have added to investor anxiety. See our latest analysis for Fiserv. It has been a tough year for Fiserv, whose leadership changes and legal turmoil come on the heels of a staggering 68.9% year-to-date share price drop. One-year total shareholder returns are also...

RB Global (NYSE:RBA) is set to announce earnings this week. Investors are watching for the company’s expected year-on-year revenue growth and technical signals that are influencing its recent trading momentum. See our latest analysis for RB Global. RB Global's share price has cooled off in the past month with a 9.2% drop; however, it remains up 8.1% year-to-date. Investors looking at the bigger picture will notice a hefty 10.5% total shareholder return over the past 12 months and a remarkable...

Wondering if Brightstar Lottery offers real value for your portfolio? Let’s take a closer look at what’s happening beneath the surface to see if now might be the right entry point. The shares have been in the spotlight lately, rising just 0.1% over the past week but dropping 7.5% over the last month, with a 5-year return that is still an impressive 133.5%. Recent headlines highlight the company’s expansion into new markets, which has caught the attention of both investors and industry...

Rayonier Inc. reported strong third quarter results on November 5, 2025, with net income rising to US$43.2 million and adjusted EBITDA nearly doubling compared to the prior year. A standout insight is the performance surge in Rayonier's Real Estate and Southern Timber segments, which significantly contributed to the company's improved financial results. We'll explore how Rayonier's robust segment performance this quarter could reshape expectations for its investment outlook and future growth...

Wondering if EPAM Systems is a bargain or overpriced? You are not alone. Let's dive into what really matters for investors curious about the company's true value. EPAM's share price recently closed at $160.91, with a minor dip of 1.2% over the past week but a rebound of 5.5% across the last 30 days. Even so, the stock is down 29.8% year-to-date and has declined by more than 20% in the last 12 months. Recent headlines have focused on the technology sector's volatility and global talent...

Goodyear Tire & Rubber (GT) delivered a 1.8% per year increase in losses over the past five years, highlighting persistent unprofitability. Revenue is forecast to rise just 0.6% a year, trailing the broader U.S. market's expected 10.4% annual growth. While profitability is still out of reach, the company is projected to rebound sharply with earnings growth of 94.05% per year, potentially achieving profitability within the next three years. See our full analysis for Goodyear Tire & Rubber. The...

Qualys (QLYS) posted robust results, with net profit margins holding high at 29%, just below last year's 29.4%. Earnings growth averaged 21.6% annually over the past five years, though the most recent year saw a more modest 8.4% gain. Looking ahead, the company expects earnings to rise 3.6% per year and revenue to expand at 6.5% annually, both trailing the broader US market. Qualys’s price-to-earnings ratio is 28.3x, below both its US Software peers and the industry average, while shares are...

United States Lime & Minerals, Inc. recently reported third-quarter 2025 results, highlighting strong sales of US$102.02 million and net income of US$38.78 million, alongside a regular quarterly cash dividend of US$0.06 per share payable December 12, 2025. The company’s improved year-over-year financials point to robust operational execution and may signal continued momentum for its core business lines. We’ll examine how United States Lime & Minerals’ rising sales growth supports its overall...

Catalyst Pharmaceuticals recently reported its third quarter 2025 financial results, posting revenue of US$148.39 million and net income of US$52.78 million, both higher than the prior year. This strong financial performance coincided with the company's recognition as one of BioSpace's Best Places to Work for the second consecutive year, highlighting its commitment to talent development in rare disease treatment. With recent earnings growth outpacing prior periods, we'll examine how these...

Aura Minerals (NasdaqGS:AUGO) remains unprofitable, with losses having widened at an annual rate of 56.9% over the past five years. The company’s revenue is forecast to grow at 5.4% per year, trailing the pace of the US market. Earnings are projected to climb by 19.67% per year, and a return to profitability is expected within the next three years. Despite a net profit margin that continues to lag due to ongoing losses, shares currently trade at $33.81, significantly below the estimated fair...

Northwest Bancshares announced third quarter 2025 results, showing increased net interest income to US$135.97 million and ongoing commercial loan growth, but a year-over-year drop in net income attributed to merger-related expenses during the Penns Woods integration. Management reported that synergy targets from the merger are on track or ahead of expectations, while the Board declared the 124th consecutive quarterly cash dividend of US$0.20 per share, continuing a long-standing dividend...

Arthur J. Gallagher (AJG) stock has experienced some downward pressure over the past month, with shares slipping nearly 20%. Investors are keeping an eye on the current valuation and recent market sentiment surrounding the insurance brokerage. See our latest analysis for Arthur J. Gallagher. The recent share price pullback comes after a strong few years for Arthur J. Gallagher, with the stock posting a 3-year total shareholder return of 35.2% and a 5-year return of 129.4%. However, momentum...

ONEOK (OKE) shares managed a slight uptick in today’s trading session. Even without any big headlines moving the needle, investors seem to be watching for subtle shifts since the company has posted mixed returns over the past 3 months and year. See our latest analysis for ONEOK. ONEOK’s latest trading bounce comes after a challenging stretch, with a year-to-date share price return of -34.88% and a one-year total shareholder return of -31.74%. Longer-term investors can still point to a solid...

Gilead Sciences recently reported strong third-quarter earnings with revenue of US$7.77 billion and net income of US$3.05 billion, raised its 2025 earnings guidance, continued share buybacks, and affirmed its quarterly dividend. An important insight is that the company achieved a very large increase in year-over-year net income and further tightened its product sales and EPS range upward for 2025, reflecting management confidence and ongoing operational momentum. We'll look at how Gilead's...